Xeriant, Inc. (XERI)

Xeriant Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Selling, General & Admin	0.99	1.3	1.71	2.05	5.74	1.83
Research & Development	0.11	0.07	0.2	-	5.27	0.37
Operating Expenses	1.1	1.37	1.91	2.05	11.01	2.2
Operating Income	-1.1	-1.37	-1.91	-2.05	-11.01	-2.2
Interest Expense	-0.31	-0.28	-1.2	-0.47	-4.77	-0.32
Earnings From Equity Investments	-	-	-	-0.1	-0.06	-
Other Non Operating Income (Expenses)	-	-	-0	-0.06	-0.04	-
EBT Excluding Unusual Items	-1.41	-1.64	-3.11	-2.68	-15.88	-2.52
Gain (Loss) on Sale of Investments	-	-	-	-0.16	-	-
Other Unusual Items	2.68	-0	0.01	-4.26	-0	-0.19
Pretax Income	1.27	-1.65	-3.1	-7.1	-15.88	-2.7
Earnings From Continuing Operations	1.18	-1.65	-3.1	-7.1	-15.88	-2.7
Minority Interest in Earnings	-	0.02	0.03	0.03	2.58	0.22
Net Income	1.18	-1.63	-3.07	-7.07	-13.3	-2.49
Net Income to Common	1.18	-1.63	-3.07	-7.07	-13.3	-2.49
Shares Outstanding (Basic)	778	621	443	340	345	225
Shares Outstanding (Diluted)	1,484	621	443	340	345	225
Shares Change (YoY)	157.61%	40.07%	30.46%	-1.57%	53.07%	330.12%
EPS (Basic)	0.00	-0.00	-0.01	-0.02	-0.04	-0.01
EPS (Diluted)	0.00	-0.00	-0.01	-0.02	-0.04	-0.01
Free Cash Flow	-0.78	-1.29	-1.43	-1.18	-6.95	-1.01
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.02	-0.00
EBITDA	-1.1	-1.36	-1.9	-2.05	-11	-
D&A For EBITDA	0	0	0	0	0.02	-
EBIT	-1.1	-1.37	-1.91	-2.05	-11.01	-2.2
Advertising Expenses	-	-	-	0.02	0.65	1.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.